The cure of oral cavity cancer had new weapon

The cure of oral cavity cancer had new remedial weapon.

The cure of cancer of 　 　 oral cavity had new remedial weapon. Yesterday, college of medicine of Shanghai traffic university is accessary hospital of the 9th people discloses external, the priority discipline of national science foundation that by this courtyard Chen Motao's researcher presents as leading role considers to achieve major breakthrough, consider to discover and confirm, develop attacks enzymatic - the many gene such as Ⅱ are the dot of active member target that element of oral cavity cancer is diagnosed and treats, can carry out " to oral cavity cancer cell individual change " to shoot kill.
Malignant tumor already became the number one killer that endangers people life health in our country, and the diagnostic standard that is aimed at oral cavity cancer still is the tectology variation that counts a tradition, and the medicaments of remedial application also does not have target tropism more, be opposite so tumor particularity is not tall, poisonous side effect is bigger also.
Teach the research group that present as leading role to study through 4 years by Chen Motao, combine group of gene of contemporary biology chip, function to learn to learn technology and method with albumen group, made successfully can diagnose to element of cancer of oral cavity scale, transfer and be able to bear or endure what property of a medicine judges is individual turn gene chip.
Medical expert passes hyperplasia of cancer of antrum of speak or sing alternately, be able to bear or endure the development of the function of gene studies related medicine, move, discovery confirmed develop attacks enzymatic - formic acid of Ⅱ , dimension accepts put oneself in another's position - albumen of cycle of β , cell 1, nuclear factor - the dot of active member target that κB and Ebp1 are treatment of oral cavity cancer, utmost ground developed tumor to turn the remedial result of cure.
Confirm via clinical applying, attack with develop enzymatic - the combination that the remedy that Ⅱ orders for action target gives priority to medicine to design for Ni Bo glucoside changes cure new plan, its treat the effect tradition of other of apparent prep above changes cure plan, already changed cure plan to apply at as first selection at present clinical. This are new therapeutics already was in unit of more than 10 medical treatment of domestic popularizes application.